Central Nervous System Embryonal Tumor — Trials

Central Nervous System Embryonal Tumor — Trials · CancerIndex

Clinical trials

Registered studies

240 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 72
Recruiting: 33
Ph III recruiting: 2
Growth YoY: —
Industry share: 4%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 101–105 of 105 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00363272	Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma	completed	Phase 1	30	National Cancer Institute (NCI)NIH	1	Jan 16, 2013	clinicaltrials
NCT00404495	Combination of Irinotecan and Temozolomide in Children With Brain Tumors.	completed	Phase 2	83	PfizerINDUSTRY	8	Apr 18, 2012	clinicaltrials
NCT00010114